This fall, Health Canada is anticipating sharing a policy consultation document about health products containing (CBD). This proposal has been in the works since 2019.
In 2022, Health Canada released a report on health products containing cannabis.
Released earlier this year, The Forward Regulatory Plan for 2024 to 2026 details regulatory initiatives that Health Canada will be proposing or finalizing in the next 2 years.
New regulatory initiatives underway
According to the Food and Drugs Act of this plan, Health Canada plans to amend the Food and Drug Regulations, Natural Health Products Regulations and Pest Control Products Regulations ensuring a consistent and flexible approach to the regulation of biocides (surface disinfectants and surface sanitizers).
Are biocides affected?
At present, biocides are regulated under separate regimes. This causes heavy difficulties for many industry regulators as they continue to work with biocides. This became clear throughout the COVID-19 pandemic.
The proposed amendments will:
- form 1 comprehensive framework for regulating biocides
- allow regulatory oversight based on risk and evolving evidence
- present a use of foreign decisions pathway
Note: The Biocides Regulations were formerly termed Regulations Amending the Food and Drug Regulations, Part C (Biocides, use of foreign decisions for disinfectants and surface sanitizers).
All of these initiatives form part of a larger spectrum of work on contemporary regulations all related to Health and Biosciences Sector Regulatory Review Roadmap.
What is Health Canada’s goal?
The intention of Health Canada is to fashion regulatory pathway for health products containing cannabidiol that would not require practitioner oversight.
How do you proceed? Get assisted by Quality Smart Solutions
For detailed insights into these regulatory changes and ongoing consultations, reach out to our team of former Health Canada experts at Quality Smart Solutions. We help ensure compliance with modernized regulations governing natural health products (NHPs) and non-prescription drugs, enhancing safety and quality standards across Canada while facilitating business growth and innovation. Fill in the form below and let’s get started!
